Ionis Pharmaceuticals IONS Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's common stock?
- Ionis Pharmaceuticals (IONS) reported common stock of 300M in Q1 2026.
- How has Ionis Pharmaceuticals's common stock changed year-over-year?
- Ionis Pharmaceuticals's common stock decreased by 0.0% year-over-year, from 300M to 300M.
- What is the long-term trend for Ionis Pharmaceuticals's common stock?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's common stock has grown at a 363.7% compound annual growth rate (CAGR), from 140K to 300M.
- What does common stock mean?
- The accounting value of all issued common shares based on their par value.
- How do you interpret common stock?
- Increases typically reflect the issuance of new shares for capital raising or employee compensation plans.
- How does common stock compare across companies?
- Standardized equity accounting entry across all public companies.